2025 International Speakers

Professor Roslyn B. Mannon, MD

Dr. Mannon is a professor of medicine, pathology, microbiology, and immunology at the University of Nebraska Medical Center, vice-chair for academic development and research mentoring, and associate chief of nephrology for research. Dr. Mannon is a fellow of the American Society of Nephrology and the American Society of Transplantation. She received her medical degree from Duke University, completing an internal medicine internship, residency and nephrology fellowship and chief residency at Duke.

Her career includes serving as Medical Director for the Kidney/Pancreas NIDDK intramural transplant program and at the Birmingham VA Medical Center and Section Chief of Transplant Nephrology at the University of Alabama at Birmingham. Dr. Mannon is a past president of the AST and is a deputy editor of the American Journal of Transplantation. She is the chair of Women in Transplantation, an initiative of the Transplantation Society, chair of the Policy and Advocacy Committee of the American Society of Nephrology, and co-chair of the Scientific Registry of Transplant Recipients Review Committee. She is a trustee of the Banff Allograft Pathology Foundation.

She was recently named a UNMC distinguished scientist for 2022. She is board certified in internal medicine and nephrology.

Professor, Division of Nephrology
Vice Chair of Research, Department of Internal Medicine
Nephrology Associate, Chief of Research, University of Nebraska
Immediate past Chair of Women in Transplantation

Dr Peter Nickerson, MD, FRCPC, FCAHS

Dr. Nickerson, a distinguished professor of internal medicine and immunology at the University of Manitoba, is a clinical nephrologist at the Health Sciences Centre in Winnipeg and a medical consultant for the Transplant Immunology Laboratory at Shared Health.

His research program is focused on the mechanisms underlying transplant rejection, non-invasive techniques for diagnosing kidney transplant rejection, and health system design to improve access to transplants and outcomes for patients.

Dr Megan Sykes, MD

Dr. Sykes is the Michael J. Friedlander Professor of Medicine and Professor of Microbiology & Immunology and Surgical Sciences (in Surgery), Columbia University. Dr. Sykes is the founding Director of the Columbia Center for Translational Immunology and serves as Director of Research for the Transplant Initiative and as Director of Bone Marrow Transplantation Research at Columbia. Dr. Sykes joined Columbia University in April, 2010 from Massachusetts General Hospital/Harvard Medical School, where she was the Harold and Ellen Danser Professor of Surgery and Professor of Medicine (Immunology) and Associate Director of the Transplantation Biology Research Center. Dr. Sykes has over 39 years’ experience in transplantation biology and Type 1 diabetes research, including translational research from animals to clinical trials and mechanistic studies of human transplant recipients. She is currently Past President of the Federation of Clinical Immunology Societies (FOCIS). Dr. Sykes received numerous honors and awards, including the Medawar Prize in 2018 and is a member of the National Academy of Medicine and of the Association of American Physicians.

Dr Cameron R. Wolfe, MBBS(Hons), MPH, FIDSA, FAST
Cameron Wolfe is a Professor of Medicine, in the Division of Infectious Disease at Duke University Medical Center, USA. Cameron's initial training was based in Melbourne, but his work now revolves around clinical care for transplant and immunosuppressed patients as well as the safe transplantation of donors who carry known and unrecognized infections. In addition, his research interests are in HIV transplantation, vaccine responsiveness in immunosuppressed hosts, and management of respiratory viral infections. He was a past Chair of the Disease Transmission Advisory Committee, and a Board Member of the UNOS/OPTN , administering transplant services in the US. He is the current Secretary of the Transplant Infectious Disease section at The Transplantation Society, and a co-faculty of the Duke Human Vaccine Institute.